Oncohematology

Title Publication Date Language Citations
RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS2018/05/1125
STANDARDIZATION OF FLOW CYTOMETRIC MINIMAL RESIDUAL DISEASE MONITORING IN CHILDREN WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. RUSSIA–BELARUS MULTICENTER GROUP EXPERIENCE2016/01/0124
Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease2020/10/1617
ANEMIA OF CHRONIC DISEASE: FEATURES OF PATHOGENESIS AND POSSIBLE THERAPEUTIC CORRECTION (LITERATURE REVIEW AND RESULTS OF OWN RESEARCH)2018/05/1114
Anemia of chronic diseases: the important aspects of pathogenesis and treatment2016/03/3113
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors2017/01/0112
EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS2017/01/0111
Strategy of medical, psychological and social rehabilitation for children with haematological and oncological diseases2015/06/0310
New proteasome inhibitors in the management of multiple myeloma2019/07/2610
MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)2017/01/019
Integrated laboratory coagulation tests in hypercoagulation diagnosis and thrombosis risk assessment. Part I. The pathophysiology of thrombosis and hypercoagulation2015/10/089
Successful use of ultrasound elastography in the preliminary intermediate evaluation of therapeutic response in patients with Hodgkin’s lymphoma2019/12/228
Cell-binding microarray application in diagnosis of hairy cell leukemia2015/06/047
Pathogenetic features of anemia of chronic diseases in patients with malignant neoplasms and rheumatic pathology2020/12/077
Differential diagnosis of thrombocytopenes2017/01/016
Brentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience2016/03/315
Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition2020/07/165
Evaluation of the possibilities of shear wave elastography for differentiation of lymphomatous and reactive changes of superficial lymph nodes2020/04/195
Treatment of double-refractory multiple myeloma2021/09/105
Prevention and management of bortezomib-induced peripheral neuropathy in patients with multiple myeloma2022/04/144
Clinical features of secondary acute myeloid leukemia in children2020/12/074
Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction2021/11/114
Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case2022/11/064
Toxicity assessment of acute lymphoblastic leukemia treatment protocol ALL IC-BFM 20022022/07/204
Micrometastases identification in malignant tumors2016/03/314
Clinical, laboratory, and morphological characteristics of kidney damage in lymphoproliferative disorders2017/01/014
Successful experience in the use of ultrasound elastography in the differentiating of lymphomatous and metastatic superficial lymphadenopathy2020/07/164
Erdheim–Chester disease. Literature review and clinical case2020/07/164
Minimal residual disease in plasma cell (multiple) myeloma: flow cytometric approaches2020/04/194
Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization2015/12/234